Tamara Glyn
Overview
Explore the profile of Tamara Glyn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi S, Hanna L, Cho D, Garg P, Glyn T, Gurland B, et al.
Colorectal Dis
. 2025 Jan;
27(1):e17300.
PMID: 39853906
Aim: Cryptoglandular anal fistulas carry a substantial burden to quality of life. Surgery is the only effective curative treatment but requires balancing fistula healing against pain, wounds and continence impairment....
2.
Thompson N, Glyn T, Kerridge D, Koea J
ANZ J Surg
. 2024 Oct;
PMID: 39350503
Background: This research investigates the potential for collaboration of Rongoā Māori, the Indigenous healing practices of Māori, with New Zealand's contemporary healthcare system. It aims to bridge the gap between...
3.
Bone E, Kumar S, Richards S, McCombie A, Chalmers-Watson T, Glyn T, et al.
ANZ J Surg
. 2024 Sep;
94(10):1806-1811.
PMID: 39225334
Background: Sessile serrated lesions (SSL) account for up to 30% of colorectal carcinoma pathogenesis. With multiple classification changes and improvements in colonoscopy equipment and technique, historical reporting may have underestimated...
4.
Wall C, Bensley R, Glyn T, Haines M, Rowbotham D, Bissett I, et al.
Nutrients
. 2024 Jul;
16(13).
PMID: 38999853
Preoperative exclusive enteral nutrition (EEN) improves nutritional status, reduces intestinal inflammation, and likely improves surgical outcomes. Crohn's disease exclusion diet with partial enteral nutrition (CDED) also reduces intestinal inflammation but...
5.
Brown K, Solomon M, Koh C, Sutton P, Aguiar Jr S, Bezerra T, et al.
Ann Surg
. 2024 May;
PMID: 38747145
Objective: To establish globally applicable benchmark outcomes for pelvic exenteration (PE) in patients with locally advanced primary (LARC) and recurrent rectal cancer (LRRC), using outcomes achieved at highly specialised centres....
6.
Thompson N, Morley-Bunker A, McLauchlan J, Glyn T, Eglinton T
BJS Open
. 2024 Apr;
8(2).
PMID: 38637299
Background: Risk evaluation of lymph node metastasis for early-stage (T1 and T2) colorectal cancers is critical for determining therapeutic strategies. Traditional methods of lymph node metastasis prediction have limited accuracy....
7.
Waddell O, Teo Y, Thompson N, McCombie A, Glyn T, Frizelle F
Expert Rev Anticancer Ther
. 2024 Apr;
24(5):313-323.
PMID: 38619285
Background: The incidence of early-onset colorectal cancer (EOCRC) is increasing. International guidelines state that treatment should not differ from that of older patients. Several studies have shown that patients under...
8.
Waddell O, Pearson J, McCombie A, Marshall H, Purcell R, Keenan J, et al.
BMC Cancer
. 2024 Apr;
24(1):456.
PMID: 38609870
Background: The incidence of early-onset colorectal cancer (EOCRC), diagnosed before age 50, has been rising in many countries in the past few decades. This study aims to evaluate this trend...
9.
Glyn T, Williams S, Whitehead M, Eglinton T, West N, Purcell R
Front Oncol
. 2024 Mar;
14:1247106.
PMID: 38505585
Objective: Chronic colonic inflammation seen in inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). Colitis-associated cancers (CAC) are molecularly different from sporadic CRC. This study aimed...
10.
Crean R, Glyn T, McCombie A, Frizelle F
ANZ J Surg
. 2024 Mar;
94(6):1151-1160.
PMID: 38486505
Background: Watch and wait (W&W) in complete clinical responders after neoadjuvant chemoradiotherapy has increasingly robust data supporting its oncological safety. Recently, studies have assessed the real-world costs of this strategy...